104 related articles for article (PubMed ID: 183591)
1. Alternate-day prednisone: preliminary report of a double-blind controlled study.
Howard FM; Duane DD; Lambert EH; Daube JR
Ann N Y Acad Sci; 1976; 274():596-607. PubMed ID: 183591
[TBL] [Abstract][Full Text] [Related]
2. Long-term prednisone followed by thymectomy in myasthenia gravis.
Mann JD; Johns TR; Campa JF; Muller WH
Ann N Y Acad Sci; 1976; 274():608-22. PubMed ID: 1066998
[TBL] [Abstract][Full Text] [Related]
3. Corticotropin and corticosteroids in generalized myasthenia gravis: comparative studies and role in management.
Brunner NG; Berger CL; Namba T; Grob D
Ann N Y Acad Sci; 1976; 274():577-95. PubMed ID: 183590
[TBL] [Abstract][Full Text] [Related]
4. Effects of alternate-day prednisone therapy on respiratory function in myasthenia gravis.
Newball HH; Brahim SA
Thorax; 1976 Aug; 31(4):410-3. PubMed ID: 968798
[TBL] [Abstract][Full Text] [Related]
5. Long-term treatment of myasthenia gravis with alternate-day prednisone. Report on 15 patients.
Pinelli P; Tonali P; Scoppetta C
Eur Neurol; 1974; 12(3):129-41. PubMed ID: 4426321
[No Abstract] [Full Text] [Related]
6. Psychiatric effects of alternate day steroid therapy.
Cordess C; Folstein M; Drachman D
Br J Psychiatry; 1981 Jun; 138():504-6. PubMed ID: 7296180
[TBL] [Abstract][Full Text] [Related]
7. [Alternate day prednisone treatment in myasthenia].
Mares A; Nisipeanu P; Lazăr T; Tudoran C
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1974; 19(5):395-401. PubMed ID: 4549646
[No Abstract] [Full Text] [Related]
8. Randomized Trial of Thymectomy in Myasthenia Gravis.
Wolfe GI; Kaminski HJ; Aban IB; Minisman G; Kuo HC; Marx A; Ströbel P; Mazia C; Oger J; Cea JG; Heckmann JM; Evoli A; Nix W; Ciafaloni E; Antonini G; Witoonpanich R; King JO; Beydoun SR; Chalk CH; Barboi AC; Amato AA; Shaibani AI; Katirji B; Lecky BR; Buckley C; Vincent A; Dias-Tosta E; Yoshikawa H; Waddington-Cruz M; Pulley MT; Rivner MH; Kostera-Pruszczyk A; Pascuzzi RM; Jackson CE; Garcia Ramos GS; Verschuuren JJ; Massey JM; Kissel JT; Werneck LC; Benatar M; Barohn RJ; Tandan R; Mozaffar T; Conwit R; Odenkirchen J; Sonett JR; Jaretzki A; Newsom-Davis J; Cutter GR;
N Engl J Med; 2016 Aug; 375(6):511-22. PubMed ID: 27509100
[TBL] [Abstract][Full Text] [Related]
9. Design of the efficacy of prednisone in the treatment of ocular myasthenia (EPITOME) trial.
Benatar M; Sanders DB; Wolfe GI; McDermott MP; Tawil R
Ann N Y Acad Sci; 2012 Dec; 1275():17-22. PubMed ID: 23278573
[TBL] [Abstract][Full Text] [Related]
10. Clinical predictors of steroid-induced exacerbation in myasthenia gravis.
Bae JS; Go SM; Kim BJ
J Clin Neurosci; 2006 Dec; 13(10):1006-10. PubMed ID: 17074487
[TBL] [Abstract][Full Text] [Related]
11. [Long term administration of oral prednisone or prednisolone in treatment of myasthenia gravis. Report of five cases (author's transl)].
Contamin F; Singer B; Mignot B; Offenstadt G; Ecoffet M
Sem Hop; 1978 Nov 18-25; 54(41-42):1213-8. PubMed ID: 216096
[TBL] [Abstract][Full Text] [Related]
12. [Corticosteroids in the treatment of myasthenia gravis. Study of 12 cases with review of the literature].
Lamartine de Assis J
Arq Neuropsiquiatr; 1975 Mar; 33(1):33-40. PubMed ID: 1164206
[TBL] [Abstract][Full Text] [Related]
13. Long-term administration of corticosteroids in myasthenia gravis.
Mann JD; Johns TR; Campa JF
Neurology; 1976 Aug; 26(8):729-40. PubMed ID: 821005
[TBL] [Abstract][Full Text] [Related]
14. Long-term corticosteroid treatment of myasthenia gravis: report of 116 patients.
Pascuzzi RM; Coslett HB; Johns TR
Ann Neurol; 1984 Mar; 15(3):291-8. PubMed ID: 6721451
[TBL] [Abstract][Full Text] [Related]
15. Benefit from alternate-day prednisone in myasthenia gravis.
Warmolts JR; Engel WK
N Engl J Med; 1972 Jan; 286(1):17-20. PubMed ID: 4331158
[No Abstract] [Full Text] [Related]
16. Tacrolimus Improves Symptoms of Children With Myasthenia Gravis Refractory to Prednisone.
Liu C; Gui M; Cao Y; Lin J; Li Y; Ji S; Bu B
Pediatr Neurol; 2017 Dec; 77():42-47. PubMed ID: 29074055
[TBL] [Abstract][Full Text] [Related]
17. Alternate-dy prednisone in a patient with myasthenia gravis.
Warmolts JR; Engel WK; Whitaker JN
Lancet; 1970 Dec; 2(7684):1198-9. PubMed ID: 4098476
[No Abstract] [Full Text] [Related]
18. A trial of mycophenolate mofetil with prednisone as initial immunotherapy in myasthenia gravis.
Muscle Study Group
Neurology; 2008 Aug; 71(6):394-9. PubMed ID: 18434639
[TBL] [Abstract][Full Text] [Related]
19. A comparison of daily and alternate-day prednisone therapy in the treatment of Duchenne muscular dystrophy.
Fenichel GM; Mendell JR; Moxley RT; Griggs RC; Brooke MH; Miller JP; Pestronk A; Robison J; King W; Signore L
Arch Neurol; 1991 Jun; 48(6):575-9. PubMed ID: 2039377
[TBL] [Abstract][Full Text] [Related]
20. Corticosteroids in management of severe, generalized myasthenia gravis. Effectiveness and comparison with corticotropin therapy.
Brunner NG; Namba T; Grob D
Neurology; 1972 Jun; 22(6):603-10. PubMed ID: 4343255
[No Abstract] [Full Text] [Related]
[Next] [New Search]
